|
|
Post by sportsrancho on Jan 20, 2018 11:26:59 GMT -5
|
|
|
|
Post by slugworth008 on Jan 20, 2018 11:36:01 GMT -5
Abbott - SO that's whose partnering with them. LOL - just kidding. Looks like a good spot though and close enough to the SNY booth for them to hear how little MNKD has kicked their salesforce's ass selling Afrezza. |
|
|
|
Post by tz on Jan 20, 2018 13:05:57 GMT -5
Mike is a smart guy. He had Go-King-Go two days ago and then followed by the ADA exhibition. That will bring many customers. Hope it is two-day event.
|
|
|
|
Post by dg1111 on Jan 20, 2018 14:21:13 GMT -5
Right at the entrance seems like a great place to be. In the past, it seems that we were tucked into a corner near the back. This is much better.
|
|
|
|
ADA
Jan 20, 2018 14:57:42 GMT -5
Post by mnkdfann on Jan 20, 2018 14:57:42 GMT -5
Right at the entrance seems like a great place to be. Judging by my reading of the Orange County Convention Center floor-plan, the MNKD booth is near AN entrance but some distance from the main entrance(s). Overall, though, I agree it looks like a pretty decent location. There were certainly far worse spots to end up. www.occc.net/Planner-Interactive-Floor-Plans |
|
|
|
Post by mnholdem on Jan 20, 2018 16:19:22 GMT -5
There appear to be many currently-unassigned booths near by. It will be interesting to see what other companies set up shop next to MannKind. Also, according to the color-code legend, the MannKind isn't rented yet.
It's on hold (white). |
|
|
|
Post by kc on Jan 20, 2018 22:52:48 GMT -5
I can’t open with my iPhone but if they have reserved a booth early that is positive since they waited till the last minute in the past. Good for MannKind.
I posted this last week on another thread.
The STAT study is probably being saved for ADA 2018 in Orlando FL.
You then have later that month in Orlando the ADA.... Jun 22 - 26, 2018 | Orlando, Florida
professional.diabetes.org/meeting/scientific-sessions/78th-scientific-sessions
Abstract submission dates:
Abstract Submission Deadlines
Abstract guidelines: professional.diabetes.org/sites/professional.diabetes.org/files/media/2018_late_breaking_abstract_submission_guidelines.pdf
Regular Abstract Submission
October 2, 2017-January 8, 2018
Late Breaking Abstract Submission February 1, 2018-March 12,2018
|
|
|
|
ADA
Jan 21, 2018 8:15:14 GMT -5
Post by pantaloons on Jan 21, 2018 8:15:14 GMT -5
I'm just trying to get a sense of the likelihood that the STAT study results will be reported at the ADA conference. Will MNKD announce beforehand that this will be the venue at which these results will be presented? It seems like a very ideal time to present the findings.
On another note, assuming that the STAT study finds that Afrezza is indeed superior to injectable mealtime insulin, how long will it take for insurance coverage and the FDA label to change? I realize this is a highly variable and multifactorial process that likely also depends on the analysis of the data itself (and therefore is inherently unpredictable at this point), but can we expect insurance/FDA label changes in the next 1-2 years vs. 5+ years, etc.?
|
|
|
|
Post by peppy on Jan 21, 2018 10:12:26 GMT -5
I'm just trying to get a sense of the likelihood that the STAT study results will be reported at the ADA conference. Will MNKD announce beforehand that this will be the venue at which these results will be presented? It seems like a very ideal time to present the findings. On another note, assuming that the STAT study finds that Afrezza is indeed superior to injectable mealtime insulin, how long will it take for insurance coverage and the FDA label to change? I realize this is a highly variable and multifactorial process that likely also depends on the analysis of the data itself (and therefore is inherently unpredictable at this point), but can we expect insurance/FDA label changes in the next 1-2 years vs. 5+ years, etc.? The likelihood is high the stat study will be released for the June ada meeting. one year later for any label movement. The study has to be submitted to the ada and then the clock starts for a year. |
|
|
|
Post by joeypotsandpans on Jan 21, 2018 12:11:23 GMT -5
What stands out to me is being right next to the Abbott booth and the new Libre that will be on display  ....nothing like instant real time BG mgmt. |
|
|
|
Post by xoxoxoxo on Jan 21, 2018 14:21:08 GMT -5
I can't believe how many years I've been following where and whether MNKD gets a booth at this conference. It's been a damn roller coaster over the years. It's really unfortunate given the technology.
I really don't think any of this matters anymore though. I'm convinced the only thing that matters at this point is refills. We're getting plenty of new scripts, but if people don't stay on the drug it's pointless.
|
|
|
|
Post by boca1girl on Jan 21, 2018 14:41:37 GMT -5
I can't believe how many years I've been following where and whether MNKD gets a booth at this conference. It's been a damn roller coaster over the years. It's really unfortunate given the technology. I really don't think any of this matters anymore though. I'm convinced the only thing that matters at this point is refills. We're getting plenty of new scripts, but if people don't stay on the drug it's pointless. It’s pretty obvious that yoU’re right about the refills, but the reasons for the lack of refills needs to be determined and corrected. If 75% is due to lack of or poor insurance coverage, then that takes top priority. If cost is not the issue, then how do we help the users get the good results we know are possible and continue with Afrezza? MNKD needs to reach out to every PWD that tried Afrezza but stopped and understand why. |
|
|
|
Post by sportsrancho on Jan 21, 2018 15:14:17 GMT -5
Agree,
How much time are the reps dedicating to training the doctors, or the nurse practitioners? And how much time are they taking with the patients?
Vdex gets 95% retention rate! And I think that’s a combination of dealing with the insurance companies themselves, and taking the time to make sure the patient understands it, and gets results.
|
|
|
|
Post by lennymnkd on Jan 21, 2018 16:54:36 GMT -5
I can see how patients would take Vdex more seriously and delicate themselves to learning ; a doctors office doesn’t seem like the right environment to get a good grip on the nuances of inhaled insulin no matter how interested in learning , something to be said for VDEX .
|
|
|
|
Post by agedhippie on Jan 21, 2018 17:29:12 GMT -5
Agree, How much time are the reps dedicating to training the doctors, or the nurse practitioners? And how much time are they taking with the patients? Vdex gets 95% retention rate! And I think that’s a combination of dealing with the insurance companies themselves, and taking the time to make sure the patient understands it, and gets results. I think it's the case that Vdex gets the motivated patients. If you have gone to the effort of finding Vdex in the first place then you are probably going to put in the work. I am not sure how much time a PCP has to work through the titration process with every patient. It's like fight camp really, half the battle is finding that it exists (here is a link - Fight Camp  tickets usually sell out in hours...) |
|
....nothing like instant real time BG mgmt. 
tickets usually sell out in hours...)